NCT04901234 - Adaptive RadioTherapy for OroPharynx Cancer | Biotech Hunter

Enrollment

120

Participants

Timeline

Start Date

July 30, 2021

Primary Completion Date

December 31, 2024

Study Completion Date

December 31, 2026

Conditions

Oropharynx CancerRadiotherapy; ComplicationsRadiotherapy Side EffectDysphagiaMRI

Interventions

RADIATION

Standard radiotherapy +/- chemotherapy

No radiotherapy adaptation unless major dosimetric deviation

RADIATION

Experimental radiotherapy +/- chemotherapy

Systemic MRI-based radiotherapy adaptation mid-treatment

Trial Locations (2)

NOT_YET_RECRUITING

Austin Health, Melbourne

RECRUITING

Centre Hospitalier de l'Université de Montréal, Montreal